Valuation: Caplin Point Laboratories Limited

Market Cap 17TCr 181.48Cr 162.28Cr 150.14Cr 135.94Cr 254.42Cr 258.59Cr 1.81TCr 714.65Cr 9.03TCr 681.13Cr 666.57Cr 29TCr P/E 2027 *
23.8x
P/E 2028 * 20.5x
Enterprise Value 17TCr 181.48Cr 162.28Cr 150.14Cr 135.94Cr 254.42Cr 258.59Cr 1.81TCr 714.65Cr 9.03TCr 681.13Cr 666.57Cr 29TCr EV / Sales 2027 *
6.89x
EV / Sales 2028 * 6.09x
Free-Float
26.56%
Yield 2027 *
0.18%
Yield 2028 * 0.18%
1 day+2.22%
1 week-1.25%
Current month-16.14%
1 month-19.90%
3 months-7.84%
6 months+32.31%
Current year+23.37%
1 week 2,177
Extreme 2177
2,306.2
1 month 2,177
Extreme 2177
2,871.8
Current year 1,502.45
Extreme 1502.45
2,990.6
1 year 1,502.45
Extreme 1502.45
2,990.6
3 years 977.1
Extreme 977.1
2,990.6
5 years 575
Extreme 575
2,990.6
10 years 180
Extreme 180
2,990.6
Manager TitleAgeSince
Chief Executive Officer 71 28/03/2015
Director of Finance/CFO - 19/02/2016
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 27/01/2010
Director/Board Member - 05/11/2025
Director/Board Member 71 28/03/2015
Change 5-day change 1-year change 3-year change Capi.($)
+2.22%-1.25%+13.50%+128.75% 177.93Cr
+0.45%+1.76%+54.96%+118.11% 1,13500Cr
+0.94%+4.20%+39.86%+75.69% 64TCr
+0.39%+0.46%+25.77%+97.40% 50TCr
+1.43%+4.56%+46.20%+66.91% 38TCr
-3.21%-3.66%+60.72%+35.68% 36TCr
-0.41%+2.23%+22.48%+48.54% 29TCr
+0.23%+3.28%+2.57%+21.89% 27TCr
+1.22%+2.81%+52.40%+63.37% 24TCr
+1.70%+1.60%+31.21%+102.44% 19TCr
Average +0.44%+1.10%+34.97%+75.88% 40.05TCr
Weighted average by Cap. +0.26%+1.63%+41.39%+81.05%

Financials

2027 *2028 *
Net sales 2.51TCr 26Cr 24Cr 22Cr 20Cr 37Cr 38Cr 262.35Cr 103.78Cr 1.31TCr 99Cr 97Cr 4.15TCr 2.83TCr 30Cr 27Cr 25Cr 22Cr 42Cr 42Cr 296.54Cr 117.3Cr 1.48TCr 111.8Cr 109.41Cr 4.69TCr
Net income 726.45Cr 7.64Cr 6.83Cr 6.32Cr 5.72Cr 11Cr 11Cr 76Cr 30Cr 379.96Cr 29Cr 28Cr 1.2TCr 841.1Cr 8.84Cr 7.91Cr 7.31Cr 6.62Cr 12Cr 13Cr 88Cr 35Cr 439.93Cr 33Cr 32Cr 1.39TCr
Net Debt - -
Projected Income Statement - Annual - Caplin Point Laboratories Limited
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
4,199
Date Price Change Volume
26/26/26 ₹2,271.50 +2.22% 9,026
23/26/23 ₹2,222.15 -1.26% 10,845
22/26/22 ₹2,250.40 +1.31% 4,226
21/26/21 ₹2,221.20 -1.81% 12,405
19/26/19 ₹2,262.05 -1.66% 4,192
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Caplin Point Laboratories Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,271.50INR
Average target price
2,765.00INR
Spread / Average Target
+21.73%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Caplin Point Laboratories Limited
  1. Stock Market
  2. Stocks
  3. CAPLIPOINT Stock